Monitored Therapeutics

What Monitored Therapeutics does

Monitored Therapeutics Inc. (MTI), founded in 2015 (per company history; firmographic data cites 2011) and headquartered in Dublin, Ohio, is a private respiratory diagnostics and remote patient monitoring company serving three primary customer segments: clinicians and healthcare practices, health systems and hospitals, and pharmaceutical sponsors/CROs conducting clinical trials. The company develops and commercializes an integrated FDA 510(k)-cleared respiratory platform comprising four products — GoSpiro (a clinical-grade connected spirometer), Lisa (an AI-powered avatar coaching assistant providing real-time, ATS/ERS-aligned breath-by-breath guidance in 20+ languages), GoClinic (clinical workflow software), and GoMobile (patient-facing home monitoring application). Together, these products deliver standardized spirometry testing across clinic and home environments, with reported metrics of 4M+ tests completed, 95% ATS/ERS-aligned acceptability, and 93% clinically actionable results.

MTI's business model is multi-stream. Revenue derives from GoSpiro hardware device sales to health systems and clinical practices, recurring subscription/usage-based fees for the GoClinic and GoMobile software platform (including the Lisa coaching layer), and clinical trial services for pharma sponsors and CROs, which include protocol configuration, centralized expert review, and analysis-ready data delivery across 17+ respiratory indications. Pricing is not publicly disclosed; the company uses quote-based 'Request a Demo' and 'Schedule a Demo' CTAs indicating a consultative enterprise sales motion directed at health system administrators, clinical decision-makers, and clinical trial sponsors. The company holds FDA 510(k) clearance for GoSpiro and maintains a security and compliance program covering HIPAA, GDPR, 21 CFR Part 11, PIPEDA, and SOC2 Type 2 standards.

The company is venture-backed (most recent round: $3.5M led by Tamarind Hill in October 2021; approximately $5.09M raised cumulatively across three disclosed rounds) and led by CEO Whit Champagne with co-founders Michael Taylor (CCO) and Alex Stenzler (CSO), supported by COO Jim Kamnikar and CTO Mac Liaw. The board includes Mike Kaufmann, former CEO of Cardinal Health, and Mark Shary, Managing Partner at Tamarind Hill. With 11–50 employees, MTI operates at a modest scale relative to its $500M+ addressable patient population and remains in an early-commercial stage of growth.

Name

Monitored Therapeutics

Legal name

Monitored Therapeutics, Inc.

Website

https://monitoredrx.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

Monitored Therapeutics Inc. (MTI) is a private respiratory diagnostics company offering an FDA 510(k)-cleared platform combining connected spirometry hardware, AI-powered avatar coaching, and clinical workflow software to deliver standardized lung function testing across clinic and home settings for clinicians, health systems, and clinical trial sponsors.

Ownership category

akta.pro rank

Product category

Digital Health

NAICS

Medical and Diagnostic Laboratories (62151), Offices of Other Health Practitioners (6213)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Medical Laboratories (8071)

akta.pro primary industry

Pulmonary Function Testing (PFT) & Spirometry Equipment (HLAHAGAH)

akta.pro secondary industries

Connected Therapeutics & Smart Drug Delivery Monitoring (HLACAFAL), Pulmonology & Sleep Medicine Telemedicine Platforms (HLALAGAF)

Keywords

• Remote patient monitoring
• Respiratory diagnostics
• Spirometry platform
• Decentralized clinical trials
• Digital health platform

Headquarters

HQ city

Dublin

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales

Revenue model

1. Remote Patient Monitoring Platform: Subscription or usage-based model for access to the MTI respiratory platform including GoSpiro devices, GoClinic/GoMobile applications, and Lisa coaching. Revenue derived from health systems, hospitals, and clinical practices implementing respiratory monitoring programs.
2. Clinical Trial Services: Revenue from pharmaceutical sponsors and CROs for standardized respiratory endpoints across decentralized clinical trials. Includes protocol configuration, centralized data review, and analysis-ready data delivery.
3. GoSpiro Device Sales: Hardware sales of FDA 510(k)-cleared GoSpiro spirometry devices for use across clinical and home settings.

Pricing tiers

Go-to-market motion3 records

Distribution channels2 records

Marketing channels3 records

Core offering

Monitored Therapeutics provides an FDA 510(k)-cleared respiratory platform that unifies lung function testing across clinic and home settings. The offering combines a clinical-grade spirometer (GoSpiro), an AI-powered avatar coaching assistant (Lisa), and structured workflow applications (GoClinic for clinical environments and GoMobile for patient home use) to deliver standardized, ATS/ERS-aligned respiratory testing for healthcare providers, health systems, and clinical trial sponsors.

Product overview

MTI (Monitored Therapeutics, Inc.) offers a unified respiratory platform comprising four integrated products: GoSpiro (an FDA 510(k)-cleared clinical-grade spirometer), Lisa (an AI-powered avatar coaching assistant), GoClinic (structured clinical workflow software), and GoMobile (patient home-monitoring application). Together these products deliver consistent, high-quality respiratory testing across clinic and home environments — enabling real-time coaching, standardized execution, and actionable clinical data for clinicians, health systems, and clinical trial sponsors.

Differentiator

Problem solved

Functional benefit

Brands

• GoSpiro: FDA-cleared clinical-grade spirometer designed for consistent performance across clinic and home settings, ensuring every test starts from the same standard.
• Lisa
• GoClinic
• GoMobile

Products and services

• GoSpiro

Quantifiable outcome

• 4 Million+ tests completed across clinical trials and patient care settings
• +6 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature6 records

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Emerging players

• Sparo Health: Sparo Health provides connected respiratory monitoring hardware and software for asthma and COPD patients, with a focus on pediatric and adult adherence and outcomes. Comparable as a connected respiratory RPM company targeting similar patient populations.
• TidalSense: TidalSense is an AI-powered respiratory diagnostics company with a regulatory-cleared platform for COPD/asthma detection. Comparable as a smaller emerging player using AI to improve respiratory testing accuracy and accessibility.
• Aluna (Respira Labs): Aluna (Respira Labs) develops connected spirometry and AI-driven respiratory monitoring tools for at-home and clinical use. Comparable as an emerging respiratory hardware-plus-AI company addressing similar patient/provider use cases.

Direct peers

• Adherium: Adherium provides connected inhaler sensors and a remote respiratory monitoring platform serving patients, providers, and clinical trial sponsors. Directly comparable as a respiratory RPM and clinical trials data company.
• MIR (Medical International Research): MIR manufactures portable spirometers and respiratory diagnostics for clinical, occupational, and telehealth use, with growing emphasis on connected and remote testing. Directly comparable as a spirometry hardware company serving similar end users.
• Propeller Health: Propeller Health (acquired by ResMed) provides digital respiratory health platforms combining sensors, apps, and analytics for asthma and COPD management. Directly comparable as a respiratory-focused remote monitoring company serving patients, providers, and pharma sponsors with software-driven engagement.
• ndd Medical Technologies: ndd Medical Technologies designs and manufactures PFT and spirometry devices (EasyOne) with ultrasound-based flow sensing for clinical and portable use. Directly comparable as a hardware-led spirometry company serving clinicians, hospitals, and occupational health.
• Vitalograph: Vitalograph is a long-established manufacturer of spirometry and pulmonary function testing equipment used in clinical, occupational, and clinical trial settings. Directly comparable as a spirometry hardware company with clinical and research customers.

Broad incumbents

• ResMed: ResMed is a global leader in sleep and respiratory care with growing digital health capabilities (Propeller Health). Comparable as a large incumbent serving sleep/respiratory patients and providers with overlapping market reach and resources.
• Philips Respiratory Care: Philips is a large medical device incumbent offering spirometry, PFT, and connected respiratory solutions as part of a broader hospital and consumer health portfolio. Comparable as a large established competitor with overlapping clinical and home respiratory offerings.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks3 records

Key highlights7 records

Customer concentration

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds3 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Monitored Therapeutics